| Year |
Citation |
Score |
| 2021 |
Barnes NM, Ahern GP, Becamel C, Bockaert J, Camilleri M, Chaumont-Dubel S, Claeysen S, Cunningham KA, Fone KC, Gershon M, Di Giovanni G, Goodfellow NM, Halberstadt AL, Hartley RM, Hassaine G, ... ... Teitler M, et al. International Union of Basic and Clinical Pharmacology. CX. Classification of Receptors for 5-hydroxytryptamine; Pharmacology and Function. Pharmacological Reviews. 73: 310-520. PMID 33370241 DOI: 10.1124/pr.118.015552 |
0.578 |
|
| 2015 |
Herrick-Davis K, Grinde E, Lindsley T, Teitler M, Mancia F, Cowan A, Mazurkiewicz JE. Native serotonin 5-HT2C receptors are expressed as homodimers on the apical surface of choroid plexus epithelial cells. Molecular Pharmacology. 87: 660-73. PMID 25609374 DOI: 10.1124/Mol.114.096636 |
0.54 |
|
| 2014 |
Teitler M, Herrick-Davis K. Determining the oligomer number of native GPCR using florescence correlation spectroscopy and drug-induced inactivation-reactivation. Current Pharmaceutical Biotechnology. 15: 927-37. PMID 25213307 DOI: 10.2174/1389201015666140909165649 |
0.62 |
|
| 2012 |
Klein MT, Teitler M. Distribution of 5-ht(1E) receptors in the mammalian brain and cerebral vasculature: an immunohistochemical and pharmacological study. British Journal of Pharmacology. 166: 1290-302. PMID 22260342 DOI: 10.1111/j.1476-5381.2012.01868.x |
0.543 |
|
| 2012 |
Teitler M, Klein MT. A new approach for studying GPCR dimers: drug-induced inactivation and reactivation to reveal GPCR dimer function in vitro, in primary culture, and in vivo. Pharmacology & Therapeutics. 133: 205-17. PMID 22119169 DOI: 10.1016/J.Pharmthera.2011.10.007 |
0.659 |
|
| 2012 |
Rahman AA, Daoud MK, Dukat M, Herrick-Davis K, Purohit A, Teitler M, do Amaral AT, Malvezzi A, Glennon RA. Corrigendum to “Conformationally-restricted analogues and partition coefficients of the 5-HT3 serotonin receptor ligands meta-Chlorophenylbiguanide (mCPBG) and meta-Chlorophenylguanidine (mCPG)” [Bioorg. Med. Chem. Lett. 15 (2005) 3434–3438] Bioorganic & Medicinal Chemistry Letters. 22: 6526. DOI: 10.1016/J.Bmcl.2012.08.076 |
0.703 |
|
| 2011 |
Klein MT, Dukat M, Glennon RA, Teitler M. Toward selective drug development for the human 5-hydroxytryptamine 1E receptor: a comparison of 5-hydroxytryptamine 1E and 1F receptor structure-affinity relationships. The Journal of Pharmacology and Experimental Therapeutics. 337: 860-7. PMID 21422162 DOI: 10.1124/Jpet.111.179606 |
0.687 |
|
| 2011 |
Klein MT, Teitler M. Antagonist interaction with the human 5-HT(7) receptor mediates the rapid and potent inhibition of non-G-protein-stimulated adenylate cyclase activity: a novel GPCR effect. British Journal of Pharmacology. 162: 1843-54. PMID 21198551 DOI: 10.1111/j.1476-5381.2010.01194.x |
0.554 |
|
| 2011 |
Smith C, Toohey N, Knight JA, Klein MT, Teitler M. Risperidone-induced inactivation and clozapine-induced reactivation of rat cortical astrocyte 5-hydroxytryptamine₇ receptors: evidence for in situ G protein-coupled receptor homodimer protomer cross-talk. Molecular Pharmacology. 79: 318-25. PMID 21062995 DOI: 10.1124/Mol.110.069278 |
0.511 |
|
| 2011 |
DuPre A, Teitler M. Ro 04-6790 Xpharm: the Comprehensive Pharmacology Reference. 1-3. DOI: 10.1016/B978-008055232-3.62549-8 |
0.584 |
|
| 2011 |
DuPre A, Teitler M. Ro 63 - 0563 Xpharm: the Comprehensive Pharmacology Reference. 1-2. DOI: 10.1016/B978-008055232-3.62548-6 |
0.643 |
|
| 2011 |
DuPre A, Teitler M. BIMU8 Xpharm: the Comprehensive Pharmacology Reference. 1-6. DOI: 10.1016/B978-008055232-3.61321-2 |
0.563 |
|
| 2010 |
Teitler M, Toohey N, Knight JA, Klein MT, Smith C. Clozapine and other competitive antagonists reactivate risperidone-inactivated h5-HT7 receptors: radioligand binding and functional evidence for GPCR homodimer protomer interactions. Psychopharmacology. 212: 687-97. PMID 20827463 DOI: 10.1007/S00213-010-2001-X |
0.674 |
|
| 2009 |
Toohey N, Klein MT, Knight J, Smith C, Teitler M. Human 5-HT7 receptor-induced inactivation of forskolin-stimulated adenylate cyclase by risperidone, 9-OH-risperidone and other "inactivating antagonists". Molecular Pharmacology. 76: 552-9. PMID 19509219 DOI: 10.1124/Mol.109.056283 |
0.595 |
|
| 2009 |
Klein MT, Teitler M. Guinea pig hippocampal 5-HT(1E) receptors: a tool for selective drug development. Journal of Neurochemistry. 109: 268-74. PMID 19200348 DOI: 10.1111/J.1471-4159.2009.05958.X |
0.667 |
|
| 2009 |
Knight JA, Smith C, Toohey N, Klein MT, Teitler M. Pharmacological analysis of the novel, rapid, and potent inactivation of the human 5-Hydroxytryptamine7 receptor by risperidone, 9-OH-Risperidone, and other inactivating antagonists. Molecular Pharmacology. 75: 374-80. PMID 18996971 DOI: 10.1124/Mol.108.052084 |
0.689 |
|
| 2007 |
Teitler M. The discovery of multiple serotonin receptor subtypes: A lesson from molecular cloning to functional expression Monoaminergic Modulation of Cortical Excitability. 1-20. DOI: 10.1007/978-0-387-72256-6_1 |
0.604 |
|
| 2006 |
Smith C, Rahman T, Toohey N, Mazurkiewicz J, Herrick-Davis K, Teitler M. Risperidone irreversibly binds to and inactivates the h5-HT7 serotonin receptor. Molecular Pharmacology. 70: 1264-70. PMID 16870886 DOI: 10.1124/Mol.106.024612 |
0.673 |
|
| 2005 |
Purohit A, Smith C, Herrick-Davis K, Teitler M. Stable expression of constitutively activated mutant h5HT6 and h5HT7 serotonin receptors: inverse agonist activity of antipsychotic drugs. Psychopharmacology. 179: 461-9. PMID 15821958 DOI: 10.1007/S00213-004-2057-6 |
0.693 |
|
| 2004 |
Dukat M, Smith C, Herrick-Davis K, Teitler M, Glennon RA. Binding of tryptamine analogs at h5-HT1E receptors: A structure-affinity investigation Bioorganic and Medicinal Chemistry. 12: 2545-2552. PMID 15110837 DOI: 10.1016/J.Bmc.2004.03.026 |
0.628 |
|
| 2004 |
Purohit A, Herrick-Davis K, Teitler M. Constitutive Activity of Brain Serotonin Receptors: Inverse Agonist Activity of Antipsychotic Drugs Frontiers in Medicinal Chemistry - Online. 1: 399-408. DOI: 10.2174/1567204043396532 |
0.676 |
|
| 2003 |
Grella B, Teitler M, Smith C, Herrick-Davis K, Glennon RA. Binding of β-carbolines at 5-HT2 serotonin receptors Bioorganic and Medicinal Chemistry Letters. 13: 4421-4425. PMID 14643338 DOI: 10.1016/J.Bmcl.2003.09.027 |
0.639 |
|
| 2003 |
Glennon RA, Daoud MK, Dukat MS, Teitler M, Herrick-Davis K, Purohit A, Syed H. Arylguanidine and arylbiguanide binding at 5-HT3 serotonin receptors: A QSAR study Bioorganic and Medicinal Chemistry. 11: 4449-4454. PMID 13129581 DOI: 10.1016/S0968-0896(03)00488-7 |
0.739 |
|
| 2003 |
Eckler JR, Chang-Fong J, Rabin RA, Smith C, Teitler M, Glennon RA, Winter JC. Behavioral characterization of 2-O-desmethyl and 5-O-desmethyl metabolites of the phenylethylamine hallucinogen DOM. Pharmacology, Biochemistry, and Behavior. 75: 845-52. PMID 12957227 DOI: 10.1016/S0091-3057(03)00159-X |
0.476 |
|
| 2003 |
Khorana N, Smith C, Herrick-Davis K, Purohit A, Teitler M, Grella B, Dukat M, Glennon RA. Binding of tetrahydrocarboline derivatives at human 5-HT5A receptors. Journal of Medicinal Chemistry. 46: 3930-7. PMID 12930153 DOI: 10.1021/Jm030080S |
0.739 |
|
| 2003 |
Rahman AA, Daoud MK, Dukat M, Herrick-Davis K, Purohit A, Teitler M, do Amaral AT, Malvezzi A, Glennon RA. Conformationally-restricted analogues and partition coefficients of the 5-HT3 serotonin receptor ligands meta-chlorophenylbiguanide (mCPBG) and meta-chlorophenylguanidine (mCPG). Bioorganic & Medicinal Chemistry Letters. 13: 1119-23. PMID 12643925 DOI: 10.1016/S0960-894X(03)00044-1 |
0.694 |
|
| 2003 |
Khorana N, Purohit A, Herrick-Davis K, Teitler M, Glennon RA. gamma-Carbolines: binding at 5-HT5A serotonin receptors. Bioorganic & Medicinal Chemistry. 11: 717-22. PMID 12538001 DOI: 10.1016/S0968-0896(02)00527-8 |
0.744 |
|
| 2003 |
Purohit A, Herrick-Davis K, Teitler M. Creation, expression, and characterization of a constitutively active mutant of the human serotonin 5-HT6 receptor. Synapse (New York, N.Y.). 47: 218-24. PMID 12494404 DOI: 10.1002/Syn.10157 |
0.767 |
|
| 2002 |
Glennon RA, Metwally K, Dukat M, Ismaiel AM, De los Angeles J, Herndon J, Teitler M, Khorana N. Ketanserin and spiperone as templates for novel serotonin 5-HT(2A) antagonists. Current Topics in Medicinal Chemistry. 2: 539-58. PMID 12052193 DOI: 10.2174/1568026023393787 |
0.654 |
|
| 2002 |
Teitler M, Herrick-Davis K, Purohit A. Constitutive activity of G-protein coupled receptors: emphasis on serotonin receptors. Current Topics in Medicinal Chemistry. 2: 529-38. PMID 12052192 DOI: 10.2174/1568026023393859 |
0.687 |
|
| 2002 |
Chang-Fong J, Addo J, Dukat M, Smith C, Mitchell NA, Herrick-Davis K, Teitler M, Glennon RA. Evaluation of isotryptamine derivatives at 5-HT(2) serotonin receptors. Bioorganic & Medicinal Chemistry Letters. 12: 155-8. PMID 11755343 DOI: 10.1016/S0960-894X(01)00713-2 |
0.648 |
|
| 2001 |
Rangisetty JB, Dukat M, Dowd CS, Herrick-Davis K, DuPre A, Gadepalli S, Teitler M, Kelley CR, Sharif NA, Glennon RA. 1-[2-methoxy-5-(3-phenylpropyl)]-2-aminopropane unexpectedly shows 5-HT(2A) serotonin receptor affinity and antagonist character. Journal of Medicinal Chemistry. 44: 3283-91. PMID 11563927 DOI: 10.1021/Jm0100739 |
0.627 |
|
| 2001 |
Dukat M, Choi YN, Teitler M, Du Pre A, Herrick-Davis K, Smith C, Glennon RA. The binding of arylguanidines at 5-HT(3) serotonin receptors: a structure-affinity investigation. Bioorganic & Medicinal Chemistry Letters. 11: 1599-603. PMID 11412989 DOI: 10.1016/S0960-894X(01)00291-8 |
0.673 |
|
| 2000 |
Herrick-Davis K, Grinde E, Teitler M. Inverse agonist activity of atypical antipsychotic drugs at human 5-hydroxytryptamine2C receptors Journal of Pharmacology and Experimental Therapeutics. 295: 226-232. PMID 10991983 |
0.593 |
|
| 2000 |
Szumlinski KK, Herrick-Davis K, Teitler M, Maisonneuve IM, Glick SD. Behavioural sensitization to cocaine is dissociated from changes in striatal NMDA receptor levels Neuroreport. 11: 2785-2788. PMID 10976963 DOI: 10.1097/00001756-200008210-00035 |
0.343 |
|
| 2000 |
Dowd CS, Herrick-Davis K, Egan C, DuPre A, Smith C, Teitler M, Glennon RA. 1-[4-(3-Phenylalkyl)phenyl]-2-aminopropanes as 5-HT(2A) partial agonists Journal of Medicinal Chemistry. 43: 3074-3084. PMID 10956215 DOI: 10.1021/Jm9906062 |
0.542 |
|
| 2000 |
Glennon RA, Dukat M, Grella B, Hong SS, Costantino L, Teitler M, Smith C, Egan C, Davis K, Mattson MV. Binding of β-carbolines and related agents at serotonin (5-HT2 and 5- HT(1A)), dopamine (D2) and benzodiazepine receptors Drug and Alcohol Dependence. 60: 121-132. PMID 10940539 DOI: 10.1016/S0376-8716(99)00148-9 |
0.678 |
|
| 2000 |
Egan C, Grinde E, Dupre A, Roth BL, Hake M, Teitler M, Herrick-Davis K. Agonist high and low affinity state ratios predict drug intrinsic activity and a revised ternary complex mechanism at serotonin 5-HT(2A) and 5-HT(2C) receptors. Synapse (New York, N.Y.). 35: 144-50. PMID 10611640 DOI: 10.1002/(Sici)1098-2396(200002)35:2<144::Aid-Syn7>3.0.Co;2-K |
0.577 |
|
| 1999 |
Smith C, Teitler M. Beta-blocker selectivity at cloned human beta1- and beta2-adrenergic receptors Cardiovascular Drugs and Therapy. 13: 123-126. PMID 10372227 DOI: 10.1023/A:1007784109255 |
0.357 |
|
| 1999 |
Hong S, Dukat M, Teitler M, Egan C, Dupre A, Herrick-Davis K, Glennon RA. 5,8-Dimethoxyharmalan: Actions at 5-HT(2A) serotonin receptors Medicinal Chemistry Research. 9: 374-388. |
0.573 |
|
| 1999 |
Khorana N, Bondarev M, Dukat M, Herrick-Davis K, Egan C, DuPre A, Smith C, Teitler M, Glennon RA. Binding of spiperone analogs at 5-HT(2A) serotonin receptors Medicinal Chemistry Research. 9: 657-667. |
0.6 |
|
| 1998 |
Herrick-Davis K, Grinde E, Gauthier C, Teitler M. Pharmacological characterization of the constitutively activated state of the serotonin 5-HT(2A) receptor Annals of the New York Academy of Sciences. 861: 140-145. PMID 9928251 DOI: 10.1111/J.1749-6632.1998.Tb10185.X |
0.704 |
|
| 1998 |
Egan C, Herrick-Davis K, Teitler M. Creation of a constitutively activated state of the 5-HT(2A) receptor by site-directed mutagenesis: Revelation of inverse agonist activity of antagonists Annals of the New York Academy of Sciences. 861: 136-139. PMID 9928250 DOI: 10.1111/J.1749-6632.1998.Tb10184.X |
0.662 |
|
| 1998 |
Metwally KA, Dukat M, Egan CT, Smith C, DuPre A, Gauthier CB, Herrick-Davis K, Teitler M, Glennon RA. Spiperone: Influence of spiro ring substituents on 5-HT(2A) serotonin receptor binding Journal of Medicinal Chemistry. 41: 5084-5093. PMID 9836624 DOI: 10.1021/Jm980452A |
0.662 |
|
| 1998 |
Egan CT, Herrick-Davis K, Teitler M. Creation of a constitutively activated state of the 5-hydroxytryptamine (2A) receptor by site-directed mutagenesis: Inverse agonist activity of antipsychotic drugs Journal of Pharmacology and Experimental Therapeutics. 286: 85-90. PMID 9655845 |
0.592 |
|
| 1998 |
Grella B, Dukat M, Young R, Teitler M, Herrick-Davis K, Gauthier CB, Glennon RA. Investigation of hallucinogenic and related β-carbolines Drug and Alcohol Dependence. 50: 99-107. PMID 9649961 DOI: 10.1016/S0376-8716(97)00163-4 |
0.491 |
|
| 1998 |
Law H, Dukat M, Teitler M, Lee DKH, Mazzocco L, Kamboj R, Rampersad V, Prisinzano T, Glennon RA. Benzylimidazolines as h5-HT(1B/1D) serotonin receptor ligands: A structure-affinity investigation Journal of Medicinal Chemistry. 41: 2243-2251. PMID 9632357 DOI: 10.1021/Jm970513P |
0.556 |
|
| 1998 |
Egan CT, Herrick-Davis K, Miller K, Glennon RA, Teitler M. Agonist activity of LSD and lisuride at cloned 5HT(2A) and 5HT(2C) receptors Psychopharmacology. 136: 409-414. PMID 9600588 DOI: 10.1007/S002130050585 |
0.667 |
|
| 1997 |
Ismaiel AM, Dukat M, Law H, Kamboj R, Fan E, Lee DKH, Mazzocco L, Buekschkens D, Teitler M, Pierson ME, Glennon RA. 2-(1-naphthyloxy)ethylamines with enhanced affinity for human 5-HT(1Dβ) (h5-HT(1B)) serotonin receptors Journal of Medicinal Chemistry. 40: 4415-4419. PMID 9435911 DOI: 10.1021/Jm970507T |
0.634 |
|
| 1997 |
Herrick-Davis K, Egan C, Teitler M. Activating mutations of the serotonin 5-HT(2C) receptor Journal of Neurochemistry. 69: 1138-1144. PMID 9282936 DOI: 10.1046/J.1471-4159.1997.69031138.X |
0.684 |
|
| 1997 |
Teitler M, Scheick C, Howard P, Sullivan JE, Iwamura T, Glennon RA. 5-HT5A serotonin receptor binding: A preliminary structure-affinity investigation Medicinal Chemistry Research. 7: 207-218. |
0.539 |
|
| 1996 |
Dukat M, Abdel-Rahman AA, Ismaiel AM, Ingher S, Teitler M, Gyermek L, Glennon RA. Structure-activity relationships for the binding of arylpiperazines and arylbiguanides at 5-HT3 serotonin receptors Journal of Medicinal Chemistry. 39: 4017-4026. PMID 8831767 DOI: 10.1021/Jm9603936 |
0.657 |
|
| 1996 |
Glennon RA, Hong SS, Bondarev M, Law H, Dukat M, Rakhit S, Power P, Fan E, Kinneau D, Kamboj R, Teitler M, Herrick-Davis K, Smith C. Binding of O-alkyl derivatives of serotonin at human 5-HT1Dβ receptors Journal of Medicinal Chemistry. 39: 314-322. PMID 8568822 DOI: 10.1021/Jm950498T |
0.551 |
|
| 1996 |
Archer S, Glick SD, Maisonneuve IM, Bidlack JM, Xu JY, Teitler M, Sebastian A, El-Hamouly W, Hutchinson I. Suppression of morphine and cocaine self-administration in rats by a mixed mu antagonist-kappa agonist (N-CBM-TAMO) and a long-acting selective D1 antagonist (AS-300) Bioorganic and Medicinal Chemistry Letters. 6: 1139-1144. DOI: 10.1016/0960-894X(96)00186-2 |
0.311 |
|
| 1996 |
Casev C, Herrick-Davis K, Teitler M. 5HT2A receptor mutagenesis reveals a receptor which has radioligand binding properties indicative of constitutive activity Faseb Journal. 10. |
0.62 |
|
| 1996 |
Herrick-Davis K, Roe L, Casev C, Teitler M. Mutant SHT2C serotonin receptors display ligand binding properties consistent with constitutive activity Faseb Journal. 10. |
0.463 |
|
| 1995 |
Pearl SM, Herrick-Davis K, Teitler M, Glick SD. Radioligand-binding study of noribogaine, a likely metabolite of ibogaine. Brain Research. 675: 342-4. PMID 7796150 DOI: 10.1016/0006-8993(95)00123-8 |
0.415 |
|
| 1995 |
Zimmerberg B, Smith CD, Weider JM, Teitler M. The development of beta 1-adrenoceptors in brown adipose tissue following prenatal alcohol exposure. Alcohol (Fayetteville, N.Y.). 12: 71-7. PMID 7748518 DOI: 10.1016/0741-8329(94)00077-Q |
0.326 |
|
| 1995 |
Ismaiel AM, Arruda K, Teitler M, Glennon RA. Ketanserin analogues: The effect of structural modification on 5-HT2 serotonin receptor binding Journal of Medicinal Chemistry. 38: 1196-1202. PMID 7707322 DOI: 10.1021/Jm00007A016 |
0.608 |
|
| 1994 |
Glennon RA, Hong SS, Dukat M, Teitler M, Davis K. 5-(Nonyloxy)tryptamine: A novel high-affinity 5-HTIDβ serotonin receptor agonist Journal of Medicinal Chemistry. 37: 2828-2830. PMID 8071931 DOI: 10.1021/Jm00044A001 |
0.652 |
|
| 1994 |
Glennon RA, Dukat M, El-Bermawy M, Law H, De Los Angeles J, Teitler M, King A, Herrick-Davis K. Influence of amine substituents on 5-HT2A versus 5-HT2C binding of phenylalkyl- and indolylalkylamines Journal of Medicinal Chemistry. 37: 1929-1935. PMID 8027974 DOI: 10.1021/Jm00039A004 |
0.542 |
|
| 1994 |
Du YL, Wilcox BD, Teitler M, Jeffrey JJ. Isolation and characterization of the rat 5-hydroxytryptamine type 2 receptor promoter: Constitutive and inducible activity in myometrial smooth muscle cells Molecular Pharmacology. 45: 1125-1131. PMID 8022406 |
0.568 |
|
| 1994 |
Teitler M, Herrick-Davis K. Multiple serotonin receptor subtypes: Molecular cloning and functional expression Critical Reviews in Neurobiology. 8: 175-188. PMID 7923395 |
0.634 |
|
| 1993 |
Fitzgerald LW, Ratty AK, Teitler M, Gross KW, Glick SD. Specificity of behavioral and neurochemical dysfunction in the chakragati mouse: a novel genetic model of a movement disorder Brain Research. 608: 247-258. PMID 8495359 DOI: 10.1016/0006-8993(93)91465-5 |
0.38 |
|
| 1993 |
Rydelek-Fitzgerald L, Wilcox BD, Teitler M, Jeffrey JJ. Serotonin-dependent collagenase induction in rat myometrial smooth muscle cells: Mediation by the 5-HT2 receptor Molecular and Cellular Endocrinology. 91: 67-74. PMID 8472855 DOI: 10.1016/0303-7207(93)90256-J |
0.679 |
|
| 1993 |
Fitzgerald LW, Teitler M. Quantitative autoradiographic analysis of [3H]carfentanil binding to mu opiate receptors in the rat brain Synapse. 14: 154-159. PMID 8392757 DOI: 10.1002/Syn.890140208 |
0.467 |
|
| 1993 |
Ismaiel AM, De Los Angeles J, Teitler M, Ingher S, Glennon RA. Antagonism of 1-(2,5-dimethoxy-4-methylphenyl)-2-aminopropane stimulus with a newly identified 5-HT2- versus 5-HT1C-selective antagonist Journal of Medicinal Chemistry. 36: 2519-2525. PMID 8355253 DOI: 10.1021/Jm00069A010 |
0.648 |
|
| 1993 |
Rydelek-Fitzgerald L, Wilcox BD, Teitler M, Jeffrey JJ. Serotonin-mediated 5-HT2 receptor gene regulation in rat myometrial smooth muscle cells Molecular and Cellular Endocrinology. 92: 253-259. PMID 8319829 DOI: 10.1016/0303-7207(93)90016-D |
0.655 |
|
| 1993 |
Minnear FL, DeMichele MAA, Leonhardt S, Andersen TT, Teitler M. Isoproterenol antagonizes endothelial permeability induced by thrombin and thrombin receptor peptide Journal of Applied Physiology. 75: 1171-1179. PMID 7901194 |
0.329 |
|
| 1992 |
Miller KJ, Teitler M. Quantitative autoradiography of 5-CT-sensitive (5-HT1D) and 5-CT-insensitive (5-HT1E) serotonin receptors in human brain. Neuroscience Letters. 136: 223-6. PMID 1641195 DOI: 10.1016/0304-3940(92)90054-B |
0.439 |
|
| 1992 |
Glennon RA, Raghupathi R, Bartyzel P, Teitler M, Leonhardt S. Binding of phenylalkylamine derivatives at 5-HT1C and 5-HT2 serotonin receptors: evidence for a lack of selectivity. Journal of Medicinal Chemistry. 35: 734-40. PMID 1542100 DOI: 10.1021/Jm00082A014 |
0.678 |
|
| 1992 |
Herndon JL, Ismaiel A, Ingher SP, Teitler M, Glennon RA. Ketanserin analogues: Structure-affinity relationships for 5-HT2 and 5-HT1C serotonin receptor binding Journal of Medicinal Chemistry. 35: 4903-4910. PMID 1479590 DOI: 10.1021/Jm00104A017 |
0.643 |
|
| 1992 |
Glennon RA, Teitler M, Sanders-Bush E. Hallucinogens and serotonergic mechanisms. Nida Research Monograph. 119: 131-5. PMID 1435968 |
0.596 |
|
| 1992 |
Deecher DC, Teitler M, Soderlund DM, Bornmann WG, Kuehne ME, Glick SD. Mechanisms of action of ibogaine and harmaline congeners based on radioligand binding studies Brain Research. 571: 242-247. PMID 1377086 DOI: 10.1016/0006-8993(92)90661-R |
0.468 |
|
| 1992 |
Leonhardt S, Gorospe E, Hoffman BJ, Teitler M. Molecular pharmacological differences in the interaction of serotonin with 5-hydroxytryptamine1c and 5-hydroxytryptamine2 receptors Molecular Pharmacology. 42: 328-335. PMID 1355262 |
0.668 |
|
| 1992 |
Fitzgerald LW, Miller KJ, Ratty AK, Glick SD, Teitler M, Gross KW. Asymmetric elevation of striatal dopamine D2 receptors in the chakragati mouse: neurobehavioral dysfunction in a transgenic insertional mutant. Brain Research. 580: 18-26. PMID 1354555 DOI: 10.1016/0006-8993(92)90922-V |
0.37 |
|
| 1992 |
Demchyshyn L, Sunahara RK, Miller K, Teitler M, Hoffman BJ, Kennedy JL, Seeman P, Van Tol HH, Niznik HB. A human serotonin 1D receptor variant (5HT1D beta) encoded by an intronless gene on chromosome 6. Proceedings of the National Academy of Sciences of the United States of America. 89: 5522-6. PMID 1351684 DOI: 10.1073/Pnas.89.12.5522 |
0.461 |
|
| 1992 |
Miller KJ, King A, Demchyshyn L, Niznik H, Teitler M. Agonist activity of sumatriptan and metergoline at the human 5-HT1D beta receptor: further evidence for a role of the 5-HT1D receptor in the action of sumatriptan. European Journal of Pharmacology. 227: 99-102. PMID 1330643 DOI: 10.1016/0922-4106(92)90149-P |
0.639 |
|
| 1992 |
Miller K, Weisberg E, Fletcher PW, Teitler M. Membrane-bound and solubilized brain 5HT3 receptors: Improved radioligand binding assays using bovine area postrema or rat cortex and the radioligands 3H-GR65630, 3H-BRL43694, and 3H-LY278584 Synapse. 11: 58-66. PMID 1318585 DOI: 10.1002/Syn.890110108 |
0.59 |
|
| 1992 |
Weisberg E, Teitler M. Novel high‐affinity 3H‐serotonin binding sites in rat and bovine brain tissue Drug Development Research. 26: 225-234. DOI: 10.1002/Ddr.430260303 |
0.417 |
|
| 1991 |
Raghupathi RK, Rydelek-Fitzgerald L, Teitler M, Glennon RA. Analogues of the 5-HT1A serotonin antagonist 1-(2-methoxyphenyl)-4-[4-(2-phthalimido)butyl]piperazine with reduced alpha 1-adrenergic affinity. Journal of Medicinal Chemistry. 34: 2633-8. PMID 1652026 DOI: 10.1021/Jm00112A043 |
0.549 |
|
| 1990 |
Appel NM, Mitchell WM, Garlick RK, Glennon RA, Teitler M, De Souza EB. Autoradiographic characterization of (±)-1-(2,5-dimethoxy-4-[125I] iodophenyl)-2-aminopropane ([125I]DOI) binding to 5-HT2 and 5-HT(1c) receptors in rat brain Journal of Pharmacology and Experimental Therapeutics. 255: 843-857. PMID 2243353 |
0.636 |
|
| 1990 |
Teitler M, Leonhardt S, Weisberg EL, Hoffman BJ. 4-[125I]iodo-(2,5-dimethoxy)phenylisopropylamine and [3H]ketanserin labeling of 5-hydroxytryptamine2 (5HT2) receptors in mammalian cells transfected with a rat 5HT2 cDNA: Evidence for multiple states and not multiple 5HT2 receptor subtypes Molecular Pharmacology. 38: 594-598. PMID 2233696 |
0.623 |
|
| 1990 |
TEITLER M, LEONHARDT S, APPEL NM, DE SOUZA EB, GLENNON RA. Receptor Pharmacology of MDMA and Related Hallucinogens Annals of the New York Academy of Sciences. 600: 626-638. PMID 1979215 DOI: 10.1111/J.1749-6632.1990.Tb16915.X |
0.689 |
|
| Show low-probability matches. |